ASK1

ANTIBODY polyclonal manufacturer Cat# NBP1-39922<br />supplied by Novus Biologicals<br />No shipping to USA/Canada Immunogen = recombinant (partial), C-terminal liquid, PBS, glycerol, affinity purified ASK1 recombinant others not tested IgG ASK1/MAP3K5

ASK1

ANTIBODY polyclonal manufacturer Cat# NBP1-32576<br />supplied by Novus Biologicals<br />No shipping to USA/Canada Immunogen = recombinant protein fragment contain a sequence corresp. to a region within aa978-1362 of human MAP3K5 liquid, Tris-glycine,

PAPER Herskovits AZ, Growdon JH

Sharpen that needle.

Arch Neurol. 2010 Aug;67(8):918-20. PubMed: 20697041

Protein Aggregation: It’s Not Just for Disease Anymore

RESEARCH NEWS 2010-08-15 Research News The accumulation of insoluble protein deposits is the hallmark of many neurodegenerative diseases, including Alzheimer disease. Now, a new study suggests that age-related protein aggregation might be widespread even in healthy organisms. In

Triple Confirmation: AD Footprint in CSF of Cognitively Normal People

RESEARCH NEWS 2010-08-15 Research News In clinical research, a first-time finding may rouse intrigue, but it’s generally independent confirmations of the data that give them potential to leave an indelible mark. That’s why a study of cerebrospinal fluid (CSF) biomarkers of Alzhei

PAPER Yoon IS, Au Q, Barber JR, Ng SC, Zhang B

Development of a high-throughput screening assay for cytoprotective agents in rotenone-induced cell death.

Anal Biochem. 2010 Dec 15;407(2):205-10. PubMed: 20705047

PAPER Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M

Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology.

Eur J Neurosci. 2010 Aug;32(3):409-22. PubMed: 20704592

PAPER Jouve L, Salin P, Melon C, Kerkerian-Le Goff L

Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease.

J Neurosci. 2010 Jul 21;30(29):9919-28. PubMed: 20660274

PAPER Li X, Zhang Y, Xie P, Piao J, Hu Y, Chang M, Liu T, Hu L

Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI.

BMC Neurosci. 2010;11:95. PubMed: 20704702

PAPER Wen PJ, Osborne SL, Meunier FA

Dynamic control of neuroexocytosis by phosphoinositides in health and disease.

Prog Lipid Res. 2011 Jan;50(1):52-61. PubMed: 20705095

PAPER Vandrovcova J, Anaya F, Kay V, Lees A, Hardy J, de Silva R

Disentangling the role of the tau gene locus in sporadic tauopathies.

Curr Alzheimer Res. 2010 Dec;7(8):726-34. PubMed: 20704554

PAPER Jazwa A, Cuadrado A

Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases.

Curr Drug Targets. 2010 Dec;11(12):1517-31. PubMed: 20704549

PAPER Kobak KA

Inaccuracy in clinical trials: effects and methods to control inaccuracy.

Curr Alzheimer Res. 2010 Nov;7(7):637-41. PubMed: 20704557

PAPER Pflanzner T, Kuhlmann CR, Pietrzik CU

Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease.

Curr Alzheimer Res. 2010 Nov;7(7):578-90. PubMed: 20704558

PAPER Marra C, Ferraccioli M, Vita MG, Quaranta D, Gainotti G

Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI.

Curr Alzheimer Res. 2011 Feb 1;8(1):24-31. PubMed: 20704559